iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)

CAPS Rating: 4 out of 5

Exchange Traded Funds

Results 1 - 20 of 36 : 1 2 Next »

Recs

0
Member Avatar TerryHoodSr (58.02) Submitted: 2/3/2016 10:47:07 AM : Outperform Start Price: $253.78 IBB Score: -0.15

IBB 255 TP 380 52wk 251-400
Top holdings include some of the most respected names in biotech: Celgene, Biogen, Amgen, Gilead Sciences, and Regeneron Pharmaceuticals.

Recs

0
Member Avatar graybell (< 20) Submitted: 1/28/2016 1:34:41 PM : Outperform Start Price: $264.50 IBB Score: -3.63

oversold

Recs

0
Member Avatar optioncoach (84.80) Submitted: 1/4/2016 3:00:07 PM : Outperform Start Price: $325.21 IBB Score: -16.45

Biotech Pull back. Does China have anything to do with Biotechs?... anyway. 3.5% pull back and I think you have to try to get some solid positions on.

Recs

0
Member Avatar alansfinance (38.95) Submitted: 1/3/2016 8:52:43 PM : Outperform Start Price: $331.15 IBB Score: -17.23

Time of the year to b ebuying Biotechs

Recs

0
Member Avatar motto1628 (< 20) Submitted: 10/6/2015 3:08:45 PM : Outperform Start Price: $301.79 IBB Score: -11.12

aging population

Recs

0
Member Avatar manirg (< 20) Submitted: 8/6/2015 12:06:59 PM : Outperform Start Price: $370.04 IBB Score: -21.69

beaten down

Recs

1
Member Avatar mhammond00 (< 20) Submitted: 4/4/2015 10:57:41 PM : Outperform Start Price: $341.85 IBB Score: -17.40

If the previous 30 years were dominated by a semiconductor / IT revolution, the next 30 will be dominated by biotech. I'm a scientist working now at a large biotech, but I'm not a biologist by training (I'm a physicist - used to work in semiconductors). I can tell you that the pace of technology innovation in biotech right now is nothing short of breathtaking. Medicine will be completely transformed 20-30 years from now. While I'm not smart enough to know which micro or small cap biotech will or won't make it, biotech ETF's like IBB, FBT, etc are a great way to ride this wave, and will continue to destroy the broader market for the next decades. I cannot emphasize this enough - the scientific tools are now in place to understand and manipulate biology in ways that will completely transform medicine as we know it.

Recs

1
Member Avatar tiomiguel (62.36) Submitted: 3/23/2015 6:57:49 PM : Outperform Start Price: $358.81 IBB Score: -18.93

The biotech sector has been taking names and kicking butts for more than 10 years, and I think it still has a lot of life left in it, in spite of claims of "frothiness" and "bubbles." In fact, this ETF has done better than mid-, small-, or large-cap stock ETFs in both bear and bull markets in recent years. IBB also has the broadest number of holdings (150) of any biotech ETF, lessening the impact of any one company's uncertain fortunes.

Recs

2
Member Avatar DrGoldin (99.46) Submitted: 1/22/2015 3:24:33 PM : Outperform Start Price: $317.29 IBB Score: -13.39

Almost every day you read about some breakthrough results from a biotech company you've never heard of. What better way to make sure you get a piece of all that than to buy the biggest biotech ETF?

Recs

0
Member Avatar Sophos2 (84.31) Submitted: 12/2/2014 3:10:03 PM : Underperform Start Price: $306.87 IBB Score: +8.21

OVERBOUGHT

Recs

0
Member Avatar theredtomato (55.69) Submitted: 6/8/2014 2:51:27 PM : Outperform Start Price: $246.06 IBB Score: +6.55

Biotech is poised to better the market over the next 5 years. IBB should do a bit better than the general biotech industry because of its focus on larger equities.

Recs

0
Member Avatar rofgile (99.42) Submitted: 1/15/2014 10:17:24 PM : Outperform Start Price: $243.61 IBB Score: +1.84

Science and drug development are not doing well, but biotech and life sciences companies are on a tear!

Recs

2
Member Avatar aaronsadowsky (< 20) Submitted: 9/5/2013 9:21:56 AM : Outperform Start Price: $201.60 IBB Score: +12.07

This is my first CAP and IBB did well yday

Recs

0
Member Avatar garrah (< 20) Submitted: 5/12/2013 8:38:42 PM : Outperform Start Price: $179.59 IBB Score: +25.52

Biotech is a safety net for now until energy cost catches up to demand,

Recs

1
Member Avatar EmmyKaye (31.42) Submitted: 4/24/2013 5:03:50 PM : Outperform Start Price: $170.96 IBB Score: +29.07

Bio tech will continue to lead the market

Recs

1
Member Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:35:17 PM : Outperform Start Price: $133.26 IBB Score: +52.16

Biotechs are strong this year.

Recs

2
Member Avatar ravens9111 (< 20) Submitted: 3/26/2012 6:13:47 PM : Outperform Start Price: $123.53 IBB Score: +71.68

Playing individual biotech stocks is risky business. This is probably the least risky way to play the sector without taking a chance of waking up one morning to see the company's drug was rejected and opens down 50%+ on an FDA rejection.

Recs

0
Member Avatar bIlluminati (36.21) Submitted: 3/2/2012 2:44:31 PM : Underperform Start Price: $118.98 IBB Score: -75.22

Price action here just looks off.

Recs

1
Member Avatar Mary953 (68.94) Submitted: 7/10/2011 3:13:41 PM : Outperform Start Price: $108.29 IBB Score: +91.37

My choices in Biotech are an absolute disaster. Nonetheless, I realize that the sector has some wonderful successes and the needs of the boomer generation plus some "newly discovered" illnesses require new medicines. That makes Biotech a sector to have a presence in.

Porte is our resident expert in this area and I am choosing this at his suggestion. It is worth noting that the only Biotech firms that have ever rewarded me - on CAPS or RL - are the ones that Porte has suggested to me. His suggestions are enough for me to add this to CAPS if not to add RL funds to.

Recs

0
Member Avatar Biotech2010 (26.08) Submitted: 1/26/2010 8:52:06 PM : Outperform Start Price: $81.24 IBB Score: +138.24

84.25

Results 1 - 20 of 36 : 1 2 Next »

Featured Broker Partners